Cargando…
晚期非小细胞肺癌HER2基因突变靶向治疗进展
Lung cancer is the most common malignancy tumor. Non-small cell lung cancer (NSCLC) accounts for about 85% of lung cancer. Human epidermal growth factor receptor-2 (HER2) is a tyrosine kinase receptor in ERBB/HER family, which activates downstream signal transduction with other family members such a...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7786225/ https://www.ncbi.nlm.nih.gov/pubmed/33357319 http://dx.doi.org/10.3779/j.issn.1009-3419.2020.101.49 |